Eye Pharma: Clinical Trials

1 trial sponsored by Eye Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1

Follow Eye Pharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of the Anti-inflammatory Effects of Norflo Oro in Acute Relapses of HLA-B27 Associated Autoimmune Uveitis
Norflo Oro, Placebo for Norflo Oro - Uveitis
Early Phase 1CompletedEye Pharma492018-12-192022-03-28

Conditions studied

Recurrence (1)  ·  Uveitis (1)

Countries

United States (1)

Top investigators

Pia Allegri (1)

Results publications

PMID 35353651